GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vetoquinol SA (LTS:0O1O) » Definitions » Debt-to-EBITDA

Vetoquinol (LTS:0O1O) Debt-to-EBITDA : 0.17 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vetoquinol Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Vetoquinol's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €9.9 Mil. Vetoquinol's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €11.2 Mil. Vetoquinol's annualized EBITDA for the quarter that ended in Dec. 2024 was €125.2 Mil. Vetoquinol's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Vetoquinol's Debt-to-EBITDA or its related term are showing as below:

LTS:0O1O' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.11   Med: 0.19   Max: 1.51
Current: 0.19

During the past 13 years, the highest Debt-to-EBITDA Ratio of Vetoquinol was 1.51. The lowest was 0.11. And the median was 0.19.

LTS:0O1O's Debt-to-EBITDA is ranked better than
82.69% of 676 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs LTS:0O1O: 0.19

Vetoquinol Debt-to-EBITDA Historical Data

The historical data trend for Vetoquinol's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vetoquinol Debt-to-EBITDA Chart

Vetoquinol Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 0.13 0.15 0.16 0.19

Vetoquinol Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.13 0.17 0.14 0.17

Competitive Comparison of Vetoquinol's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Vetoquinol's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vetoquinol's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vetoquinol's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vetoquinol's Debt-to-EBITDA falls into.


;
;

Vetoquinol Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Vetoquinol's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.908 + 11.215) / 114.077
=0.19

Vetoquinol's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.908 + 11.215) / 125.192
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2024) EBITDA data.


Vetoquinol  (LTS:0O1O) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Vetoquinol Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vetoquinol's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vetoquinol Business Description

Traded in Other Exchanges
Address
Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.

Vetoquinol Headlines

No Headlines